Dallas Nephrology Associates’ physicians led by Dr. Pedro Vergne-Marini assisted in the development of the Methodist Medical Center transplant program, which performed their first kidney transplant in 1981.
Dallas Nephrology Associates opened Dallas Transplant Institute. Dallas Transplant Institute provides medical care for post-kidney and kidney/pancreas transplant patients and coordinates the medical evaluation for patients with CKD who have applied for kidney transplantation.
Dr. Thomas Parker, III, helped to lead the National Cooperative Dialysis Study (NCDS). NCDS was the first randomized and controlled trial that investigated the impact of dialysis doses on patients’ outcomes. Prior to this study, there was no standardized target BUN or HD session duration among patients with ESRD. The NCDS provided the first evidence that monitoring small solute clearance was an effective means of quantification of dialysis dose.